ST
SAL Trading Portfolio holdings
AUM
$49.9M
This Quarter Return
+3.03%
1 Year Return
+19.88%
3 Year Return
+19.8%
5 Year Return
–
10 Year Return
–
AUM
$20.5M
AUM Growth
+$20.5M
(-29%)
Cap. Flow
-$7.7M
Cap. Flow
% of AUM
-37.5%
Top 10 Holdings %
Top 10 Hldgs %
98.8%
Holding
20
New
3
Increased
2
Reduced
3
Closed
3
Top Buys
| 1 |
ASML
ASML
|
$4.91M |
| 2 |
ArcelorMittal
MT
|
$2.31M |
| 3 |
Nokia
NOK
|
$810K |
| 4 |
Logitech
LOGI
|
$247K |
| 5 |
AstraZeneca
AZN
|
$101K |
Top Sells
| 1 |
BP
BP
|
$10.1M |
| 2 |
HSBC
HSBC
|
$3.26M |
| 3 |
argenx
ARGX
|
$1.67M |
| 4 |
Rio Tinto
RIO
|
$402K |
| 5 |
Novartis
NVS
|
$343K |
Sector Composition
| 1 | Technology | 45.01% |
| 2 | Materials | 19.4% |
| 3 | Healthcare | 17.05% |
| 4 | Consumer Staples | 8.12% |
| 5 | Energy | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ASML
ASML
$292B
| $4.91M | 7.84% | +6,484 | New | +$4.91M |
|
|
2
Nokia
NOK
$23.1B
| $4.09M | 6.53% | 1,194,964 +236,900 | +25% | +$810K |
|
|
3
ArcelorMittal
MT
$25.4B
| $2.31M | 3.69% | +81,300 | New | +$2.31M |
|
|
4
Rio Tinto
RIO
$102B
| $1.68M | 2.68% | 22,500 -5,400 | -19% | -$402K |
|
5
AB InBev
BUD
$122B
| $1.67M | 2.66% | 25,800 | – | – |
|
|
6
argenx
ARGX
$43.6B
| $1.43M | 2.28% | 3,749 -4,400 | -54% | -$1.67M |
|
|
7
AstraZeneca
AZN
$248B
| $1.37M | 2.18% | 20,300 +1,500 | +8% | +$101K |
|
8
Shell
SHEL
$215B
| $1.32M | 2.12% | 20,122 | – | – |
|
9
Stellantis
STLA
$27.8B
| $814K | 1.3% | 34,900 | – | – |
|
|
10
Novartis
NVS
$245B
| $707K | 1.13% | 7,000 -3,400 | -33% | -$343K |
|
|
11
Logitech
LOGI
$15.3B
| $247K | 0.4% | +2,600 | New | +$247K |
|
12
Barclays
BCS
$68.9B
| – | – | 0 | – | – |
|
13
BHP
BHP
$142B
| – | – | 0 | – | – |
|
|
14
BP
BP
$90.8B
| – | – | -261,800 | Closed | -$10.1M |
|
15
British American Tobacco
BTI
$124B
| – | – | 0 | – | – |
|
16
Deutsche Bank
DB
$67.7B
| – | – | 0 | – | – |
|
17
GSK
GSK
$79.9B
| – | – | -7,000 | Closed | -$254K |
|
|
18
HSBC
HSBC
$224B
| – | – | -82,700 | Closed | -$3.26M |
|
19
Novo Nordisk
NVO
$251B
| – | – | 0 | – | – |
|
20
Vodafone
VOD
$28.8B
| – | – | 0 | – | – |
|